Literature DB >> 8896785

Treatment of bipolar depression with carbamazepine: results of an open study.

S C Dilsaver1, S C Swann, Y W Chen, A Shoaib, B Joe, K J Krajewski, N Gruber, Y Tsai.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8896785     DOI： 10.1016/S0006-3223(96)00339-3

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN： 0006-3223            Impact factor:   13.382


× No keyword cloud information.
  4 in total

Review 1.  Bipolar depression: management options.

Authors:  Gin S Malhi; Philip B Mitchell; Shahzad Salim
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

Review 2.  Do recent efficacy data on the drug treatment of acute bipolar depression support the position that drugs other than antidepressants are the treatment of choice? A conceptual review.

Authors:  Hans-Jürgen Möller; Heinz Grunze; Karl Broich
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2005-08-04       Impact factor: 5.270

3.  Extended-release carbamazepine capsules as monotherapy in bipolar disorder : pooled results from two randomised, double-blind, placebo-controlled trials.

Authors:  Richard H Weisler; Robert Hirschfeld; Andrew J Cutler; Thomas Gazda; Terence A Ketter; Paul E Keck; Alan Swann; Amir Kalali
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

4.  Carbamazepine extended-release capsules in bipolar disorder.

Authors:  Richard H Weisler
Journal:  Neuropsychiatr Dis Treat       Date:  2006-03       Impact factor: 2.570
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.